Cintas Corporation vs 22nd Century Group Inc — how do they compare? Cintas Corporation trades at $202.41 (market cap $79.86B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Cintas Corporation is far larger — about 128460.4× 22nd Century Group Inc's market cap, and Cintas Corporation pays a 1.03% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cintas Corporation for 125 Days and 22nd Century Group Inc for 32 Days on average.
| CTAS | XXII | |
|---|---|---|
Market Cap | $79.86B | $621.67K |
Volume | 1,323,583 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $216.53 | $483.00 |
52-Week Low | $163.55 | $0.80 |
Typical Hold Time | 125 Days | 32 Days |
Enterprise Value | $82.33B | -$3.69M |
Dividend Yield | 1.03% | — |
Signals from Pluang's Aura AI — not financial advice
Cintas (CTAS) trades at $201.12, up 1.99% with a bullish technical signal. The company reported strong Q1 2027 results with revenue reaching $3.01 billion (10.9% growth) and earnings of $1.39 per share beating estimates. Fundamentals show robust profitability with 17.82% net margin and 41.25% ROE, though valuation ratios remain elevated at P/E 39.67. Recent guidance increases and consistent dividend growth support positive momentum.
The outlook remains positive with analyst consensus target of $234.60 (16.6% upside) and 40% buy ratings. Key risks include premium valuation multiples and potential economic sensitivity. The stock offers quality fundamentals but requires monitoring of margin sustainability and competitive pressures in the uniform services sector.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →